Eli Lilly & Co. stock underperforms Friday when compared to competitors
Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...
Three reasons Nvidia's stock is still compelling, and why it could rise 30% in the next year
We ran that screen on Feb. 15 last year, using data as of the market close the previous day. Nvidia's (NVDA) stock has returned 80% from Feb. 14, 2024, through Tuesday, while the S&P 500 SPX has ...
Momentum stocks like Palantir are off to a -2-
"Over the past six months, EPS revisions appear to be the most correlated factor to momentum - thus stocks across all 11 sectors with the highest EPS revisions are heavily behind the strong ...
Eli Lilly & Co. stock underperforms Monday when compared to competitors
The stock's fall snapped a four-day winning streak.
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...